A survey of children’s interstitial lung disease (ChILD) databases across the EU and an ability to identify pan-registry clinical trial cohorts

J. Carlens (Hannover, Germany), N. Ullmann (Rome, Italy), E. Kerem (Jerusalem, Israel), N. Nathan (Paris, France), R. Epaud (Créteil, France), A. Clement (Paris, France), M. Griese (Munich, Germany), D. Snijders (Padova, Italy), S. Cunningham (Edinburgh, United Kingdom)

Source: International Congress 2019 – A mixture of rare lung diseases
Session: A mixture of rare lung diseases
Session type: Poster Discussion
Number: 392
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Carlens (Hannover, Germany), N. Ullmann (Rome, Italy), E. Kerem (Jerusalem, Israel), N. Nathan (Paris, France), R. Epaud (Créteil, France), A. Clement (Paris, France), M. Griese (Munich, Germany), D. Snijders (Padova, Italy), S. Cunningham (Edinburgh, United Kingdom). A survey of children’s interstitial lung disease (ChILD) databases across the EU and an ability to identify pan-registry clinical trial cohorts. 392

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The Spanish national clinical audit on COPD exacerbations (eCOPD). Pilot study: selection of study subjects
Source: Annual Congress 2008 - COPD in the elderly - quality of life and scores in COPD
Year: 2008


Interims analysis of the EXCITING-ILD registry (registry for exploring clinical and epidemiological characteristics of interstitial lung diseases)
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016

The presence and impact of chronic kidney disease in COPD patients, data from the German COSYCONET cohort
Source: International Congress 2017 – Extrapulmonary comorbidities in COPD
Year: 2017

A strategy to select COPD cases in case-control studies: the genes–environment interaction on respiratory diseases (GEIRD) project
Source: Eur Respir J 2007; 30: Suppl. 51, 448s
Year: 2007

An international survey on genetics in clinical practice for interstitial lung disease.
Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases
Year: 2021


Collating data from major European population studies – The CADSET (Chronic airway disease early stratification) clinical research collaboration
Source: Virtual Congress 2020 – New tools for risk stratification of obstructive diseases
Year: 2020




An international prospective cohort study to develop a practical COPD disease risk index that predicts the clinical course of COPD
Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care
Year: 2009

Respiratory parameters predict mortality in COPD patients - data from the Czech multicentre research database of severe COPD.
Source: International Congress 2017 – Markers of COPD progression
Year: 2017


Interstitial lung diseases in children: The French national cohort study
Source: Annual Congress 2011 - Rare diffuse lung diseases
Year: 2011

Health resource utilisation due to IPF exacerbations in Spain: prospective, observational, multicentric study (OASIS study)
Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis
Year: 2020


The Spanish national clinical audit on COPD exacerbations. results of a pilot study: spirometry outcomes
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008


An observational study of incident diagnoses of children’s diffuse parenchymal lung disease (ChILDEU)
Source: International Congress 2018 – Primary ciliary dyskinesia and lung function tests in respiratory morbidities
Year: 2018


Development of a new prognosis index (BODS) in patients with COPD:a prospective cohort study
Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)?
Year: 2018

Characteristics and clinical management of IPF patients in Spain: prospective, observational, multicentric study (OASIS study).
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020


Economic impact of IPF exacerbations in Spain: prospective, observational, multicentric study (OASIS study)
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021


Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013

COPD therapy based on clinical phenotypes: Baseline data from the Czech multicentre research database of COPD
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015


Characteristics of subjects susceptible to exacerbation-like respiratory events in a population-based cohort: Canadian cohort obstructive lung disease (CanCOLD) study
Source: International Congress 2014 – Longitudinal studies of respiratory disease
Year: 2014


A population-based study of incidence of respiratory symptoms and asthma in relation to occupational group. A 10 years follow-up. Report from the obstructive lung disease in northern Sweden studies (OLIN)
Source: Eur Respir J 2004; 24: Suppl. 48, 499s
Year: 2004

COPD integrated disease management, from controlled trial to real-world primary care; a cohort study.
Source: Virtual Congress 2020 – Organising respiratory disease management in primary care
Year: 2020